Stock PROK PROKIDNEY CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus ProKidney Corp.

Equities

PROK

KYG7S53R1049

End-of-day quote Nasdaq
Other stock markets
 06:00:00 2024-05-22 pm EDT 		5-day change 1st Jan Change
3.51 USD -3.04% Intraday chart for ProKidney Corp. -13.44% +97.19%
May. 10 ProKidney Q1 Loss Unchanged From Year Earlier MT
May. 10 ProKidney Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Evolution of the average Target Price on ProKidney Corp.

Price target over the last 5 years

History of analyst recommendation changes

b4381010576d52812919958de10c4.HGlHHqqFgPpnBdJd4TVFLg37ZYM3tA4JV9rH8d0kF5c.SgIRcub02oMLZpYuk1kgQ2aLFtF49nZBOZaNsLtoXaB-UR9NzsvnkAtNkw~36a1d7b9a2cdf70e381c5a228ef12f8d

Analyst Recommendations on ProKidney Corp.

BofA Securities Downgrades ProKidney to Neutral From Buy, Cuts Price Target to $2 From $8 MT
BTIG Initiates ProKidney With Buy Rating, $16 Price Target MT
Jefferies Initiates ProKidney With Buy Rating, Price Target is $15 MT
Morgan Stanley Starts ProKidney at Equalweight With $13 Price Target MT
UBS Initiates Coverage on ProKidney With Buy Rating, $18 Price Target MT
Citigroup Starts ProKidney at Buy With $16 Price Target MT
BofA Securities Starts ProKidney at Buy With $14 Price Target MT
Evercore ISI Initiates Coverage on ProKidney With Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
3.37 USD
Average target price
4.4 USD
Spread / Average Target
+30.56%
High Price Target
6 USD
Spread / Highest target
+78.04%
Low Price Target
3 USD
Spread / Lowest Target
-10.98%

Consensus detail

Consensus revision (last 18 months)

Analysts covering ProKidney Corp.

BofA Securities
BTIG
Jefferies & Co.
Morgan Stanley
UBS
Citigroup
Evercore ISI

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PROK Stock
  4. Consensus ProKidney Corp.